Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017;26(3):93-105.
doi: 10.1007/s40629-017-0014-2. Epub 2017 Apr 11.

Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics

Thilo Jakob  1   2 , David Rafei-Shamsabadi  1 , Edzard Spillner  3 , Sabine Müller  1
Affiliations

Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics

Thilo Jakob et al. Allergo J Int. 2017.

Abstract

Background: The high rate of asymptomatic sensitization to Hymenoptera venom, difficulty in correctly identifying Hymenoptera and loss of sensitization over time make an accurate diagnosis of Hymenoptera venom allergy challenging. Although routine diagnostic tests encompassing skin tests and the detection of venom-specific IgE antibodies with whole venom preparations are reliable, they offer insufficient precision in the case of double sensitized patients or in those with a history of sting anaphylaxis, in whom sensitization cannot be proven or only to the presumably wrong venom.

Methods: Systematic literature research and review of current concepts of diagnostic testing in Hymenoptera venom allergy.

Results and discussion: Improvements in diagnostic accuracy over recent years have mainly been due to the increasing use of molecular allergy diagnostics. Detection of specific IgE antibodies to marker and cross-reactive venom allergens improves the discrimination between genuine sensitization and cross-reactivity, and this provides a better rationale for prescribing venom immunotherapy. The basophil activation test has also increased diagnostic accuracy by reducing the number of Hymenoptera venom sensitizations overlooked with routine tests. This paper reviews current concepts of diagnostic testing in Hymenoptera venom allergy and suggests fields for further development.

Keywords: Basophil activation test; Diagnostic algorithm; Recombinant allergens; Skin test; cross-reactive carbohydrate determinants.

PubMed Disclaimer

Conflict of interest statement

T. Jakob has received research grants and speakers honoraria from Thermo Fischer/Phadia Freiburg, Germany and Uppsala, Sweden in addition to research support from ALK-Abello, Allergy Therapeutics, Allergopharma, Cormetics Europe and Novartis. D. Rafei-Shamsabadi declares that he has no competing interests. E. Spillner is co-founder of PLS-Design. S. Müller has received speakers honoraria from Novartis, Bencard and Travel reimbursement from ALK Abello.

Figures

Fig. 1
Fig. 1
Honeybee and yellow jacket venom and their respective marker and cross-reactive allergens. Apis mellifera marker allergens: Api m 1, 3, 4 and 10; Apis mellifera potentially cross-reactive allergens: Api m 2, 5 and 12. Vespula vulgaris marker allergens: Ves v 1 and 5; Vespula vulgaris potentially cross-reactive allergens: Ves v 2, 3 and 6. HVB honeybee venom, YJV yellow jacket venom, Api m 1 Apis mellifera allergen number 1, Ves v 1 Vespula vulgaris allergen number 1
Fig. 2
Fig. 2
Recommended diagnostic algorithm for the investigation of Hymenoptera venom allergic patients. a Insect honeybee (as reported by the patient), b Insect yellow jacket (as reported by the patient), and c Insect not identified by the patient
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Schäfer T. Epidemiology of insect venom allergy. Allergo J. 2009;18:353–358. doi: 10.1007/BF03362108. - DOI
    1. Worm M, Eckermann O, Dölle S, Aberer W, Beyer K, Hawranek T, et al. Triggers and treatment of anaphylaxis. Dtsch Arztebl Int. 2014;111:367–375. - PMC - PubMed
    1. Oude Elberink JN, de Monchy JG, van der Heide S, Guyatt GH, Dubois AEJ. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J Allergy Clin Immunol. 2002;110:174–182. doi: 10.1067/mai.2002.125827. - DOI - PubMed
    1. Przybilla B, Ruëff F. Insect stings: Clinical features and management. Dtsch Arztebl Int. 2012;109:238–248. - PMC - PubMed
    1. Przybilla B, Ruëff F, Walker A, Räwer HC, Aberer W, Bauer CP, et al. Diagnosis and therapy of bee und wasp venom allergy. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologen (ÄDA), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA), der Deutschen Dermatologischen Gesellschaft (DDG) und der Deutschen Gesellschaft für Kinderund Jugendmedizin (DGKJ) in Zusammenarbeit mit der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und der Schweizerischen Gesellschaft für Allergologie und Immunologie (SGAI) Allergo J. 2011;20:318–339. doi: 10.1007/BF03362543. - DOI

LinkOut - more resources